{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:44:44Z","timestamp":1785199484839,"version":"3.55.0"},"reference-count":44,"publisher":"Bentham Science Publishers Ltd.","issue":"15","funder":[{"DOI":"10.13039\/501100003336","name":"Bulgarian National Science Fund","doi-asserted-by":"publisher","award":["DN 11\/16-2017"],"award-info":[{"award-number":["DN 11\/16-2017"]}],"id":[{"id":"10.13039\/501100003336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2019,1,10]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Drug resistance is a major cause of cancer treatment failure. Most cancer therapies involve multiple agents, to overcome it. Compounds that exhibit strong anti-tumor effect without damaging normal cells are more and more in the focus of research. Chemotherapeutic drugs, combining different moieties and functional groups in one molecule, can modulate different regulatory pathways in the cell and thus reach the higher efficacy than the agents, which affect only one cellular process.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>We tested the effect of recently synthesized ferrocene-containing camphor sulfonamide DK-164 on two breast cancer and one breast non-cancer cell lines. The cytotoxic effects were evaluated using the standard MTT-dye reduction and clonogenic assays. The apoptotic or autophagic effects were evaluated by Annexin v binding or LC3 puncta formation assays respectively. Cell cycle arrest was determined using flow cytometry. Western blot and immunofluorescent analyses were used to estimate the localization and cellular distribution of key regulatory factors NF\u03baB and p53.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Compound DK-164 has well pronounced cytotoxicity greater to cancer cells (MDA-MB-231 and MCF-7) compared to non-cancerous (MCF-10A). IC50 of the substance caused a cell cycle arrest in G1 phase and induced apoptosis up to 24 hours in both tumor cells, although being more pronounced in MCF-7, a functional p53 cell line. Treatment with IC50 concentration of the compound provoked autophagy in both tumor lines but is better pronounced in the more aggressive cancer line (MDA-MB-231).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>The tested compound DK-164 showed promising properties as a potential therapeutic agent.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871520619666190724094334","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T18:24:09Z","timestamp":1563992649000},"page":"1874-1886","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Effect of a Ferrocene Containing Camphor Sulfonamide DK-164 on Breast Cancer Cell Lines"],"prefix":"10.2174","volume":"19","author":[{"given":"Maria","family":"Schr\u00f6der","sequence":"first","affiliation":[{"name":"Institute of Molecular Biology, \u201cRoumen Tsanev\u2019\u2019, Bulgarian Academy of Sciences, bl. 21, Acad. G. Bonchev Str., Sofia 1113, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazie","family":"Yusein-Myashkova","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology, \u201cRoumen Tsanev\u2019\u2019, Bulgarian Academy of Sciences, bl. 21, Acad. G. Bonchev Str., Sofia 1113, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Petrova","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology, \u201cRoumen Tsanev\u2019\u2019, Bulgarian Academy of Sciences, bl. 21, Acad. G. Bonchev Str., Sofia 1113, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgi","family":"Dobrikov","sequence":"additional","affiliation":[{"name":"Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, bl. 9, Acad. G. Bonchev Str., Sofia 1113, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Kamenova-Nacheva","sequence":"additional","affiliation":[{"name":"Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, bl. 9, Acad. G. Bonchev Str., Sofia 1113, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordana","family":"Todorova","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology, \u201cRoumen Tsanev\u2019\u2019, Bulgarian Academy of Sciences, bl. 21, Acad. G. Bonchev Str., Sofia 1113, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evdokia","family":"Pasheva","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology, \u201cRoumen Tsanev\u2019\u2019, Bulgarian Academy of Sciences, bl. 21, Acad. G. Bonchev Str., Sofia 1113, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0116-0079","authenticated-orcid":true,"given":"Iva","family":"Ugrinova","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biology, \u201cRoumen Tsanev\u2019\u2019, Bulgarian Academy of Sciences, bl. 21, Acad. G. Bonchev Str., Sofia 1113, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199004123221505","volume":"322","author":"Sigurdsson H.","year":"1990","unstructured":"Sigurdsson H.; Baldetorp B.; Borg A.; Dalberg M.; Fern\u00f6 M.; Killander D.; Olsson H.; Indicators of prognosis in node-negative breast cancer. N Engl J Med 1990,322(15),1045-1053","journal-title":"N Engl J Med"},{"key":"ref=2","first-page":"85","volume":"35","author":"Richie R.C.","year":"2003","unstructured":"Richie R.C.; Swanson J.O.; Breast cancer: A review of the literature. J Insur Med 2003,35(2),85-101","journal-title":"J Insur Med"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jso.2930590402","volume":"59","author":"Donegan W.L.","year":"1995","unstructured":"Donegan W.L.; Follow-up after treatment for breast cancer: how much is too much? J Surg Oncol 1995,59(4),211-214","journal-title":"J Surg Oncol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00204-012-0868-5","volume":"86","author":"Burns K.A.","year":"2012","unstructured":"Burns K.A.; Korach K.S.; Estrogen receptors and human disease: An update. Arch Toxicol 2012,86(10),1491-1504","journal-title":"Arch Toxicol"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jinorgbio.2016.11.003","volume":"166","author":"Cardoso J.M.S.","year":"2017","unstructured":"Cardoso J.M.S.; Correia I.; Galv\u00e3o A.M.; Marques F.; Carvalho M.F.N.N.; Synthesis of Ag(I) camphor sulphonylimine complexes and assessment of their cytotoxic properties against cisplatin-resistant A2780cisR and A2780 cell lines. J Inorg Biochem 2017,166,55-63","journal-title":"J Inorg Biochem"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2174\/0929867033457647","volume":"10","author":"Scozzafava A.","year":"2003","unstructured":"Scozzafava A.; Owa T.; Mastrolorenzo A.; Supuran C.T.; Anticancer and antiviral sulfonamides. Curr Med Chem 2003,10(11),925-953","journal-title":"Curr Med Chem"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrm3028","volume":"12","author":"Youle R.J.","year":"2011","unstructured":"Youle R.J.; Narendra D.P.; Mechanisms of mitophagy. Nat Rev Mol Cell Biol 2011,12(1),9-14","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/ncb3392","volume":"18","author":"Oren M.","year":"2016","unstructured":"Oren M.; Kotler E.; p53 mutations promote proteasomal activity. Nat Cell Biol 2016,18(8),833-835","journal-title":"Nat Cell Biol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.drup.2018.05.001","author":"Stiewe T.","year":"2018","unstructured":"Stiewe T.; Haran T.E.; How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance. Drug Resist Updat 38 2018,27-43","journal-title":"Drug Resist Updat 38"},{"key":"ref=10","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026104","volume":"6","author":"Chen J.","year":"2016","unstructured":"Chen J.; The Cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression. Cold Spring Harb Perspect Med 2016,6(3)","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","volume":"25","author":"Bonizzi G.","year":"2004","unstructured":"Bonizzi G.; Karin M.; The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004,25(6),280-288","journal-title":"Trends Immunol"},{"key":"ref=12","volume":"9","author":"Pires B.R.B.","year":"2018","unstructured":"Pires B.R.B.; Silva R.C.M.C.; Ferreira G.M.; Abdelhay E.; NF-kappaB: Two Sides of the Same Coin. Genes (Basel) 2018,9(1)","journal-title":"Genes (Basel)"},{"key":"ref=13","first-page":"91","volume":"30","author":"Eckstein N.","year":"2011","unstructured":"Eckstein N.; Platinum resistance in breast and ovarian cancer cell lines. Journal of experimental","journal-title":"CR (East Lansing Mich)"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"9103","DOI":"10.1039\/C7NJ00619E","volume":"41","author":"Kamenova-Nacheva M.S.","year":"2017","unstructured":"Kamenova-Nacheva M.S.; Pasheva E.; Slavchev I.; Dimitrov V.; Momekov G.; Nikolova R.; Shivachev B.; Ugrinova I.; Dobrikov G.M.; Synthesis of ferrocenylmethylidene and arylidene substituted camphane based compounds as potential anticancer agents. New J Chem 2017,41(17),9103-9112","journal-title":"New J Chem"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"Mosmann T.","year":"1983","unstructured":"Mosmann T.; Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983,65(1-2),55-63","journal-title":"J Immunol Methods"},{"key":"ref=16","volume":"9","author":"Guzm\u00e1n C.","year":"2014","unstructured":"Guzm\u00e1n C.; Bagga M.; Kaur A.; Westermarck J.; Abankwa D.; ColonyArea: An ImageJ plugin to automatically quantify colony formation in clonogenic assays. PLoS One 2014,9(3)","journal-title":"PLoS One"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"Franken N.A.","year":"2006","unstructured":"Franken N.A.; Rodermond H.M.; Stap J.; Haveman J.; van Bree C.; Clonogenic assay of cells in vitro. Nat Protoc 2006,1(5),2315-2319","journal-title":"Nat Protoc"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"29794","DOI":"10.18632\/oncotarget.7631","volume":"7","author":"Luo M.","year":"2016","unstructured":"Luo M.; Fu L.; The effect of chemotherapy on programmed cell death 1\/programmed cell death 1 ligand axis: Some chemotherapeutical drugs may finally work through immune response. Oncotarget 2016,7(20),29794-29803","journal-title":"Oncotarget"},{"key":"ref=19","volume":"19","author":"Yun C.W.","year":"2018","unstructured":"Yun C.W.; Lee S.H.; The roles of autophagy in cancer. Int J Mol Sci 2018,19(11)","journal-title":"Int J Mol Sci"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.semcancer.2013.06.007","volume":"23","author":"Lorin S.","year":"2013","unstructured":"Lorin S.; Hama\u00ef A.; Mehrpour M.; Codogno P.; Autophagy regulation and its role in cancer. Semin Cancer Biol 2013,23(5),361-379","journal-title":"Semin Cancer Biol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1242\/jcs.141036","volume":"128","author":"Carlsson S.R.","year":"2015","unstructured":"Carlsson S.R.; Simonsen A.; Membrane dynamics in autophagosome biogenesis. J Cell Sci 2015,128(2),193-205","journal-title":"J Cell Sci"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1210\/rp.58.1.95","volume":"58","author":"Tian B.","year":"2003","unstructured":"Tian B.; Brasier A.R.; Identification of a nuclear factor kappa B-dependent gene network. Recent Prog Horm Res 2003,58,95-130","journal-title":"Recent Prog Horm Res"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.critrevonc.2017.11.001","volume":"120","author":"Tilborghs S.","year":"2017","unstructured":"Tilborghs S.; Corthouts J.; Verhoeven Y.; Arias D.; Rolfo C.; Trinh X.B.; van Dam P.A.; The role of nuclear factor-kappa B signaling in human cervical cancer. Crit Rev Oncol Hematol 2017,120,141-150","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/cancers3010994","volume":"3","author":"Ozaki T.","year":"2011","unstructured":"Ozaki T.; Nakagawara A.; Role of p53 in cell death and human cancers. Cancers (Basel) 2011,3(1),994-1013","journal-title":"Cancers (Basel)"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","volume":"137","author":"Vousden K.H.","year":"2009","unstructured":"Vousden K.H.; Prives C.; Blinded by the light: The growing complexity of p53. Cell 2009,137(3),413-431","journal-title":"Cell"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3727\/096504003108748429","volume":"13","author":"Gartel A.L.","year":"2003","unstructured":"Gartel A.L.; Feliciano C.; Tyner A.L.; A new method for determining the status of p53 in tumor cell lines of different origin. Oncol Res 2003,13(6-10),405-408","journal-title":"Oncol Res"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1016\/j.febslet.2010.09.021","volume":"584","author":"Naryzhny S.N.","year":"2010","unstructured":"Naryzhny S.N.; Lee H.; Proliferating cell nuclear antigen in the cytoplasm interacts with components of glycolysis and cancer. FEBS Lett 2010,584(20),4292-4298","journal-title":"FEBS Lett"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1200\/JCO.2013.50.6600","volume":"32","author":"Wickberg A.","year":"2014","unstructured":"Wickberg A.; Holmberg L.; Adami H.O.; Magnuson A.; Villman K.; Liljegren G.; Sector resection with or without postoperative radiotherapy for stage I breast cancer: 20-year results of a randomized trial. J Clin Oncol 2014,32(8),791-797","journal-title":"J Clin Oncol"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0027-5107(01)00141-5","volume":"478","author":"Kartalou M.","year":"2001","unstructured":"Kartalou M.; Essigmann J.M.; Mechanisms of resistance to cisplatin. Mutat Res 2001,478(1-2),23-43","journal-title":"Mutat Res"},{"key":"ref=30","volume":"2015","author":"Ali S.","year":"2015","unstructured":"Ali S.; Yasin G.; Zuhra Z.; Wu Z.; Butler I.S.; Badshah A.; Din I.U.; Ferrocene-based bioactive bimetallic thiourea complexes: Synthesis and spectroscopic studies. Bioinorg Chem Appl 2015,2015","journal-title":"Bioinorg Chem Appl"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1039\/CC9960000955","volume":"8","author":"Top S.","year":"1996","unstructured":"Top S.; Tang J.; Vessieres A.; Carrez D.; Provot C.; Jaouen G.; Ferrocenyl hydroxytamoxifen: A prototype for a new range of oestradiol receptor site-directed cytotoxics. Chem Commun (Camb) 1996,8,955-956","journal-title":"Chem Commun (Camb)"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0020-1693(00)00147-X","volume":"306","author":"Osella D.","year":"2000","unstructured":"Osella D.; Ferrali M.; Zanello P.; Laschi F.; Fontani M.; Nervi C.; Cavigiolio G.; On the mechanism of the antitumor activity of ferrocenium derivatives. Inorg Chim Acta 2000,306(1),42-48","journal-title":"Inorg Chim Acta"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1039\/c1nj20192a","volume":"35","author":"Pigeon P.","year":"2011","unstructured":"Pigeon P.; Top S.; Vessieres A.; Huche M.; Gormen M.; El Arbi M.; Plamont M.A.; McGlinchey M.J.; Jaouen G.; A new series of ferrocifen derivatives, bearing two aminoalkyl chains, with strong antiproliferative effects on breast cancer cells. New J Chem 2011,35(10),2212-2218","journal-title":"New J Chem"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1039\/C8DT03440K","volume":"48","author":"Singh A.","year":"2019","unstructured":"Singh A.; Lumb I.; Mehra V.; Kumar V.; Ferrocene-appended pharmacophores: An exciting approach for modulating the biological potential of organic scaffolds. Dalton Trans 2019,48(9),2840-2860","journal-title":"Dalton Trans"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1039\/C8TX00279G","volume":"8","author":"Agus H.H.","year":"2018","unstructured":"Agus H.H.; Sengoz C.O.; Yilmaz S.; Oxidative stress-mediated apoptotic cell death induced by camphor in sod1-deficient Schizosaccharomyces pombe. Toxicol Res (Camb) 2018,8(2),216-226","journal-title":"Toxicol Res (Camb)"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1016\/j.ejmech.2011.05.037","volume":"46","author":"El-Sayed N.S.","year":"2011","unstructured":"El-Sayed N.S.; El-Bendary E.R.; El-Ashry S.M.; El-Kerdawy M.M.; Synthesis and antitumor activity of new sulfonamide derivatives of thiadiazolo[3,2-a]pyrimidines. Eur J Med Chem 2011,46(9),3714-3720","journal-title":"Eur J Med Chem"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3389\/fendo.2018.00471","volume":"9","author":"Giuliani C.","year":"2018","unstructured":"Giuliani C.; Bucci I.; Napolitano G.; The role of the transcription factor nuclear factor-kappa B in thyroid autoimmunity and cancer. Front Endocrinol (Lausanne) 2018,9,471","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"25530","DOI":"10.1074\/jbc.M112.356279","volume":"287","author":"Liu F.","year":"2012","unstructured":"Liu F.; Bardhan K.; Yang D.; Thangaraju M.; Ganapathy V.; Waller J.L.; Liles G.B.; Lee J.R.; Liu K.; NF-\u03baB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression. J Biol Chem 2012,287(30),25530-25540","journal-title":"J Biol Chem"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1097-2765(04)00131-5","volume":"13","author":"Campbell K.J.","year":"2004","unstructured":"Campbell K.J.; Rocha S.; Perkins N.D.; Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell 2004,13(6),853-865","journal-title":"Mol Cell"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1046\/j.1432-1327.2000.01421.x","volume":"267","author":"Kaltschmidt B.","year":"2000","unstructured":"Kaltschmidt B.; Kaltschmidt C.; Hofmann T.G.; Hehner S.P.; Dr\u00f6ge W.; Schmitz M.L.; The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus. Eur J Biochem 2000,267(12),3828-3835","journal-title":"Eur J Biochem"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bcp.2003.08.039","volume":"67","author":"Ashikawa K.","year":"2004","unstructured":"Ashikawa K.; Shishodia S.; Fokt I.; Priebe W.; Aggarwal B.B.; Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues. Biochem Pharmacol 2004,67(2),353-364","journal-title":"Biochem Pharmacol"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrc1588","volume":"5","author":"Nakanishi C.","year":"2005","unstructured":"Nakanishi C.; Toi M.; Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 2005,5(4),297-309","journal-title":"Nat Rev Cancer"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bcp.2014.12.007","volume":"93","author":"Rai A.","year":"2015","unstructured":"Rai A.; Kapoor S.; Singh S.; Chatterji B.P.; Panda D.; Transcription factor NF-\u03baB associates with microtubules and stimulates apoptosis in response to suppression of microtubule dynamics in MCF-7 cells. Biochem Pharmacol 2015,93(3),277-289","journal-title":"Biochem Pharmacol"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"10105","DOI":"10.1158\/0008-5472.CAN-08-1846","volume":"68","author":"Georges S.A.","year":"2008","unstructured":"Georges S.A.; Biery M.C.; Kim S.Y.; Schelter J.M.; Guo J.; Chang A.N.; Jackson A.L.; Carleton M.O.; Linsley P.S.; Cleary M.A.; Chau B.N.; Coordinated regulation of cell cycle transcripts by p53-inducible microRNAs, miR-192 and miR-215. Cancer Res 2008,68(24),10105-10112","journal-title":"Cancer Res"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/173789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T06:51:19Z","timestamp":1610607079000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/173789\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":44,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2019,1,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520619666190724094334","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-03-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}